ML |
Machine Learning |
RF |
Random Forest |
MD |
Molecular Dynamics |
SF |
Scoring Function |
FBDD |
Fragment-Based Drug Design |
VS |
Virtual Screening |
MW |
Molecular Weight |
SAR |
Structure-Activity Relationship |
QSAR |
Quantitative Structure-Activity Relationship |
EF |
Enrichment Factor |
ROC |
Receiver Operating Characteristic |
PDB |
Protein Data Bank |
RMSD |
Root-Mean-Square Deviation |
MUV |
Maximum Unbiased Validation |
DUD |
Directory of Useful Decoys |
GPCR |
G-Protein-Coupled Receptor |
LADS |
Latent Actives in the Decoy Set |
BEDROC |
Boltzmann-Enhanced Discrimination of Receiver Operating Characteristic |
AUC |
Area Under the Curve |
RIE |
Robust Initial Enhancement |
DUD-E |
Directory of Useful Decoys, Enhanced |
DEKOIS |
Demanding Evaluation Kits for Objective in Silico Screening |
HTX |
High Throughput X-ray Crystallography |
RO3 |
Rule of Three |
DSF |
Differential Scanning Fluorimetry |
Rp
|
Pearson correlation coefficient |
Rs
|
Spearman rank-correlation |
BFGS |
Broyden–Fletcher–Goldfarb–Shanno |